NCT04823442View on ClinicalTrials.gov

Activation of Brown Adipose Tissue Metabolism Using Mirabegron

NACompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

January 21, 2021

Primary Completion Date

April 4, 2022

Study Completion Date

April 4, 2022

Conditions
Type 2 Diabetes
Interventions
DRUG

Mirabegron

Mirabegron: a single dose of 200 mg mirabegron (4 tablets of 50 mg)

DRUG

Bisoprolol Fumarate

a single dose of 10 mg (2 tablets of 5 mg)

Trial Locations (1)

J1H 5N4

Centre de recherche du CHUS, Sherbrooke

All Listed Sponsors
collaborator

Laval University

OTHER

lead

Université de Sherbrooke

OTHER

NCT04823442 - Activation of Brown Adipose Tissue Metabolism Using Mirabegron | Biotech Hunter | Biotech Hunter